Table 1 Comparison between patients developed hematoma expansion (group I) and those did not (group II) regarding clinical and radiological data
From: Early hematoma expansion in primary intracerebral hemorrhage: incidence and predictors
Group I (n = 28) | Group II (n = 44) | p value | ||
|---|---|---|---|---|
Age | 59.35 ± 10.51 | 54.58 ± 8.19 | 0.044* | |
Sex | Male | 13/28 (46.4%) | 20/44 (45.5%) | 0.953 |
Female | 15/28 (53.6%) | 24/44 (54.5%) | ||
Diabetes | 8/28 (28.6%) | 14/44 (31.8%) | 0.770 | |
Smoking | 13/28 (46.4%) | 6/44 (13.6%) | 0.0021* | |
Smoking index | 20.71 ± 23.36 | 2.5 ± 6.77 | < 0.0001* | |
Initial mean ABP | 140.7 ± 22.45 | 104.3 ± 12.97 | < 0.0001* | |
Initial m-NIHSS | 17.29 ± 1.97 | 17.2 ± 2.74 | < 0.0001* | |
Follow-up m-NIHSS difference | 9.32 ± 3.86 | 3 ± 1.88 | < 0.0001* | |
SMASH-U | HTN | 16/28 (57.1%) | 24/44 (54.4%) | 0.385 |
MI | 4/28 (14.3%) | 10/44 (22.7%) | ||
SD | 7/28 (25%) | 7/44 (15.9%) | ||
SVL | 1/28 (3.6%) | 3/44 (6.8%) | ||
Hematoma Sites | Lobar | 12/28 (42.9%) | 9/44 (20.5%) | 0.077 |
Deep | 13/28 (46.4%) | 28/44 (63.6%) | ||
Infratentorial | 3/28 (10.7%) | 7/44 (15.9%) | ||
Intraventricular extension | 9/28 (32.1%) | 6/44 (13.6%) | 0.059 | |
Initial hematoma volume | 31.19 ± 7.28 | 21.52 ± 5.28 | < 0.0001* | |
Hematoma expansion volume | 12.47 ± 5.36 | 1.78 ± 0.66 | < 0.0001* | |
Hematoma irregular border | 17/28 (60.7%) | 11/44 (25%) | 0.0024* | |
Blend sign | 9/28 (32.1%) | 4/44 (9.1%) | 0.013* | |
Spot sign score | 0.84 ± 0.76 | 0.11 ± 0.32 | < 0.0001* | |
Mortality | 15/28 (53.6%) | 6/44 (13.6%) | 0.0003* | |
Modified Rankin Scale | 4.72 ± 1.24 | 3.1 ± 1.008 | < 0.0001* | |